Una Terra backs AmorSui in $12.5M Series A

Una Terra is investing in AmorSui as part of the healthcare company’s $12.5 million growth round to scale reusable PPE across U.S. hospitals and prepare for expansion into Europe and Asia. The deal adds capital and commercial support as AmorSui pushes a circular alternative to single-use medical supplies.

Why it matters: - AmorSui is trying to replace single-use medical supplies with reusable PPE that can cut waste, lower long-term costs and reduce supply-chain risk for healthcare providers. - Una Terra is backing that shift with capital and scaling support as the market for more circular healthcare procurement grows. - The investment gives AmorSui added momentum at a key commercialization stage, with potential implications for how hospitals buy and dispose of protective gear.

What happened: - Una Terra, a Swiss-based early growth impact investment manager, invested in AmorSui as part of AmorSui’s $12.5 million growth financing round. - AmorSui is a Philadelphia-based healthcare technology and medical supply company focused on reusable, circular PPE. - The investment is intended to help AmorSui expand in the U.S. and prepare for international growth in Europe and Asia.

The details: - AmorSui develops reusable isolation gowns and lab coats designed to be safer, more comfortable, cost-effective and lower-waste than disposable alternatives. - The company’s reusable isolation gowns can withstand up to 100 industrial wash cycles while maintaining required protective performance. - AmorSui says the product design reduces the volume of disposable gowns entering the waste stream. - AmorSui is expanding in the U.S. through a distribution partnership with one of the three largest U.S. medical supply distributors. - Una Terra said its experience in circular economy businesses will help support AmorSui’s commercial and impact goals. - AmorSui’s model replaces repeated purchasing and disposal of single-use products with durable goods designed for reuse. - The company says that approach can help healthcare organizations reduce waste, lower PPE costs over time and reduce exposure to volatile supply chains. - The new capital will support U.S. commercialization, product innovation, supply-chain expansion and the buildout of circularity infrastructure.

Between the lines: - The deal reflects growing investor interest in circular economy companies that can pair environmental benefits with clearer economics. - AmorSui’s pitch is not only sustainability. The company is also selling resilience and cost control to healthcare buyers. - Una Terra’s involvement adds more than funding. The firm is positioning itself as a growth partner for market entry and scale. - AmorSui’s broader strategy could eventually extend beyond healthcare into other sectors that use PPE and uniforms daily, according to Luca Zerbini.

What’s next: - AmorSui will use the funding to deepen its U.S. rollout and build out the systems needed for broader international expansion. - The company is expected to keep growing its distribution footprint as it seeks more healthcare customers. - Una Terra and AmorSui are positioning the business for a next phase centered on scale, product development and circular supply chains.

The bottom line: - AmorSui is betting that reusable PPE can become a mainstream healthcare procurement model, and Una Terra is helping finance that push.